Darmstadt (Free subscription) | 02/09/2008
NOVATO, Calif. , Sept. 2 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. BMRN today announced that Jean-Jacques Bienaime , Chief Executive Officer of BioMarin, will present a ...
Red Orbit (Free subscription) | 25/08/2008
BioMarin Pharmaceutical has announced the roll-out of the national phenylketonuria demographics, outcomes and safety registry.
The San Francisco Business Times (Free subscription) | 25/08/2008
BioMarin Pharmaceutical Inc. set up a national registry for phenylketonuria patients, and clinics, offering some patients 45 days of free treatments with its drug Kuvan. (BMRN)
Red Orbit (Free subscription) | 22/08/2008
NOVATO, Calif., Aug. 21 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. announced today the roll-out of the national PKU Demographics, Outcomes and Safety Registry (PKUDOS).
PR News Wire (Free subscription) | 21/08/2008
Conference Call and Webcast to Be Held Today at 4:30 p.m. ET (21:30 CET) NOVATO, Calif., Aug. 21 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: ) announced today the roll-out of the national PKU Demographics, Outcomes and Safety Registry (PKUDOS). The registry is open to all PKU clinics within the United States, and all patients screened for Kuvan responsiveness are eligible for...
The Street (Free subscription) | 06/08/2008
But the biopharmaceutical company missed on top-line projections.
The Street (Free subscription) | 06/08/2008
But the biopharmaceutical company missed on top-line projections.
PR News Wire (Free subscription) | 05/08/2008
Second Quarter Profit Driven by Strong Revenue Growth Improved Total Revenue Guidance Conference Call and Webcast to Be Held Today at 5:00 p.m. ET (22:00 CET) NOVATO, Calif., Aug. 5 /PRNewswire-FirstCall/ -- Financial Highlights ($ in millions, except per share data) Item Q2 2008 Q2 2007 Comparison Total BioMarin Revenue $64.2 122% increase Naglazyme Net Product Revenue $35.1 67.9% increase ...
Medical News Today (Free subscription) | 23/07/2008
Children's Memorial Hospital of Chicago has announced that it has received a grant from BioMarin Pharmaceutical Inc. to support its Adult Phenylketonuria (PKU) Outreach Education Project.
Red Orbit (Free subscription) | 22/07/2008
NOVATO, Calif. and OXFORD, England, July 22 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.
Eurekalert (Free subscription) | 21/07/2008
( Children's Memorial Hospital ) Children's Memorial received a grant of $102,000 from BioMarin to conduct outreach to PKU patients who are no longer being treated at PKU clinics. Patients are encouraged to seek treatment and education.
Darmstadt (Free subscription) | 15/07/2008
NOVATO, Calif., July 15 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. NASDAQ: BMRN SWX: BMRN today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will host ...
Red Orbit (Free subscription) | 01/07/2008
NOVATO, Calif., July 1 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.
Seeking Alpha (Free subscription) | 26/06/2008
Zacks.com submits: There seem to be many reasonably priced plays within biotech at the present time, which is a very good thing in a soft market such as the one we have been slogging through. Zacks senior biotech analyst Grant Zeng, CFA was on hand to give us his perspective on the sector recently. Do you expect 2008 will be a strong year for biotech stocks? Complete Story ยป
The Street (Free subscription) | 24/06/2008
The stock's selloff Monday was a simple overreaction, say several Wall Street analysts.
